The Zhitong Finance App learned that Huaxi Securities released a research report saying that according to the annual report, H&H International Holdings (01112.HK) aims to complete the “national standard” transition before the end of the first half of '25. This will lay the foundation for overall infant formula sales to resume growth throughout '25. The company expects revenue to return to an upward trajectory in '25. According to the company's annual report, the bank predicts that 25-26 year revenue will be lowered from 138.2/14.99 billion yuan to 137.7/14.66 billion yuan, adding 15.48 billion yuan in revenue for 27 years; net profit due to mother will be lowered from 6.6/80 million yuan to 54/660 million yuan, adding 760 million yuan in net profit to mother for 27 years; EPS will be lowered from 1.02/1.24 yuan to 0.84/1.02 yuan, and an additional 27-year EPS of 1.18 yuan. The closing price of HKD 9.55 yuan on April 14, 2025 was 10/9/7 times the P/E, respectively, maintaining the “buy” rating.

Zhitongcaijing · 3d ago
The Zhitong Finance App learned that Huaxi Securities released a research report saying that according to the annual report, H&H International Holdings (01112.HK) aims to complete the “national standard” transition before the end of the first half of '25. This will lay the foundation for overall infant formula sales to resume growth throughout '25. The company expects revenue to return to an upward trajectory in '25. According to the company's annual report, the bank predicts that 25-26 year revenue will be lowered from 138.2/14.99 billion yuan to 137.7/14.66 billion yuan, adding 15.48 billion yuan in revenue for 27 years; net profit due to mother will be lowered from 6.6/80 million yuan to 54/660 million yuan, adding 760 million yuan in net profit to mother for 27 years; EPS will be lowered from 1.02/1.24 yuan to 0.84/1.02 yuan, and an additional 27-year EPS of 1.18 yuan. The closing price of HKD 9.55 yuan on April 14, 2025 was 10/9/7 times the P/E, respectively, maintaining the “buy” rating.